Latest Balance Sheet News

Page 1 of 561
Vertex Minerals’ Reward Gold Mine produced 679 ounces in its first production year, but the transition came with a A$16.4 million loss, negative operating cash flow and a formal going-concern warning. The company now faces a narrow window to prove its mechanised mining plan can lift production before debt repayments and further funding decisions bite.
Maxwell Dee
Maxwell Dee
2 Oct 2026
Metrics Real Estate Multi-Strategy Fund has released audited FY26 accounts with an unqualified KPMG opinion, reporting $28.2 million in profit after tax and 10.48 cents per unit in distributions. The accounts also expose a $10 million interest-free related-party loan and a temporary halt to applications and redemptions in underlying funds.
Victor Sage
Victor Sage
2 Oct 2026
Hammer Metals’ proposed acquisition by Austral Resources has cleared its first court stage, with ASIC registering the scheme booklet and an independent expert backing the scrip deal. Shareholders now face linked votes on the takeover and the demerger of Western Australian gold assets into an unlisted company.
Maxwell Dee
Maxwell Dee
2 Oct 2026
Heavy Minerals reported a sharply wider FY2026 loss and a $3.15 million net working capital deficit, with its auditor flagging material uncertainty over the company’s ability to continue as a going concern. The balance sheet pressure sits alongside stronger project milestones, including a post-year-end Port Gregory study and the push to fund Kanmantoo.
Maxwell Dee
Maxwell Dee
2 Oct 2026
Alkane Resources has reported a transformational FY2026, with the Mandalay merger helping lift revenue to A$935.8 million and profit after tax to A$228.7 million. The enlarged gold and antimony producer has also declared its first dividend and approved a buy-back, while setting broadly stable production guidance for FY2027.
Maxwell Dee
Maxwell Dee
2 Oct 2026
Osmond Resources’ preliminary study has put a US$2.31 billion post-tax NPV on its Spanish rare earths and mineral sands project, but the headline economics rest on a scoping-level model and a US$300 million funding requirement. The next test is whether drilling, metallurgy, permitting and financing can turn the attractive concept into a financeable mine.
Maxwell Dee
Maxwell Dee
2 Oct 2026
Capstone Copper has agreed to sell its Cozamin mine in Mexico to Luca Mining in a deal featuring US$275 million upfront and as much as US$110 million in deferred and copper-linked payments. The proposed sale would give Capstone fresh balance-sheet capacity while preserving indirect exposure to the asset through Luca shares.
Maxwell Dee
Maxwell Dee
2 Oct 2026
Aeris Environmental’s FY2026 annual report pairs international commercial progress with a $5.03 million operating cash drain, $9.22 million in net liabilities and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company says it will need extended related-party loan terms and further funding while converting its technology and chemicals pipeline into recurring revenue.
Victor Sage
Victor Sage
1 Oct 2026
Victor Group Holdings’ audited FY2025 accounts were materially worse than its preliminary figures, with loss before tax rising to AUD 9.33 million from AUD 275,449. Newly recognised impairments and a sharp increase in depreciation turned preliminary comprehensive income of AUD 48,679 into a AUD 9.06 million loss.
Victor Sage
Victor Sage
1 Oct 2026
Sports Entertainment Group has completed its NZ$130 million acquisition of MediaWorks, creating a trans-Tasman audio group with more than 5 million listeners. The combined business starts with pro forma net leverage of 1.84 times and a management target of approximately 1.2 times within two years.
Victor Sage
Victor Sage
1 Oct 2026
Pacific Current Group finished FY2026 with no financial debt, A$158 million in cash and a strategic review that could lead to a transaction, a sale or delisting. The balance-sheet repair came alongside lower underlying earnings, a statutory loss and a sharp decline in Victory Park valuations.
Claire Turing
Claire Turing
1 Oct 2026
Chimeric Therapeutics remains suspended from ASX trading after failing to lodge its FY2026 financial statements, with the company reporting an approximate $7.7 million net asset deficiency and unresolved creditor negotiations. Potential recapitalisation interest has emerged, but no binding funding or settlement agreement has been reached.
Ada Torres
Ada Torres
1 Oct 2026

Browse the archive

Full archive